Navigation Links
Islets May Lead to Diabetes Cure

Researchers take a step forward in their search for a cure for diabetes. A new study done in mice shows cells from the spleen appear to develop into insulin //producing pancreatic islet cells. This could lead to a broad application for patients with diabetes. The latest research is a follow up to the 2001 report of a treatment that cures advanced type 1 diabetes in mice. The new research focuses on the biological mechanism behind that accomplishment. David Nathan, M.D., director of the Massachusetts General Hospital Diabetes Centers, says: "These exciting findings in a mouse model of type 1 diabetes suggest that patients who are developing the disease could be rescued from further destruction of their insulin-producing cells. In addition, patients with fully established diabetes possibly could have their diabetes reversed." Type 1 diabetes happens when the body’s immune cells mistakenly attack the insulin producing islet cells of the pancreas. As islet cells die, insulin production ceases and blood sugar levels rise. This causes damage in organs throughout the body. In the first study, researchers retrained the immune system not to attack the islet cells. But researchers were not clear if the islet cells were there or if they were regenerated. The latest research shows islet regeneration was occurring and that cells were growing from both the recipient’s own cells and from the donor cells. In order to determine how the new islet cells had developed, researchers carried out the same treatment using spleen cells from healthy male donors to re-educate the immune cells of female diabetic mice. Using male and female mice, researchers could see if the cells had Y chromosomes. A separate experiment also found the regrowth of islet cells can occur in animals that have immune system re-education to eradicate their diabetes, but do not receive the donor cells. Researchers have developed a protocol to test this approach in humans, but additional grant money is need ed before a clinical trial can begi.
'"/>




Related medicine news :

1. MRI Can Monitor Transplanted Islets
2. Is Diabetes the Leading Cause of Kidney Failure in India
3. Diabetes and Depression often go hand-in-hand
4. Thirty minutes of work up per day reduces the risk of Diabetes
5. Diabetes on the rise
6. Irregular Periods Linked to Diabetes
7. Cinnamon combats Diabetes
8. Good News For Women With Gestational Diabetes
9. Processed Meat, Diabetes connection Found
10. Pancreatic Cancer may be linked to Diabetes
11. Gestational Diabetes linked to Chromosomal defici
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... MedMatchPlus+ has ... chances of acceptance to a residency in a United States hospital. Being accepted ... the U.S. , According to data released by the ECFMG®, every year, 50 ...
(Date:7/21/2017)... ... July 21, 2017 , ... Sharon ... the signature product of her research center at Bio-Logic Aqua Research® Water Life ... and the greatest number of sufferers of blindness. “We think that Nature’s Tears® ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 ... ... give insight into why concussion rates are on the rise, say researchers presenting ... Meeting today in Toronto, Ontario, Canada. , “The combination of evaluating the patterns ...
(Date:7/20/2017)... ... 2017 , ... ChenMed , a leading provider of value-based care for ... as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor of Family ... of Ambulatory Services for the UVA Health System, brings 30 years of highly relevant ...
Breaking Medicine News(10 mins):
(Date:7/21/2017)... RESEARCH TRIANGLE PARK, N.C. , July ... UTHR ) announced today that it will report ... opens on Thursday, July 27, 2017. ... on Thursday, July 27, 2017, at 9:00 a.m. Eastern ... international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference ...
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/15/2017)... Enterin Inc., a Philadelphia -based ... today announced the completion of a $12.7 million Series A ... as well as the participation of existing investors. ... the support of New Ventures III and our current investors, ... the potential of our platform technology to transform the course ...
Breaking Medicine Technology: